This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
ratio-Atorvastatin recall (2014-07-08)
- Starting date:
- July 8, 2014
- Posting date:
- July 17, 2014
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-40675
Recalled products
- ratio-Atorvastatin 10 mg
- ratio-Atorvastatin 20 mg
- ratio-Atorvastatin 40 mg
- ratio-Atorvastatin 80 mg
Reason
Stability out-of-specification results at the 12-month time-point for an impurity.
Depth of distribution
Wholesalers and retailers across Canada
Affected products
A. ratio-Atorvastatin 10 mg
DIN, NPN, DIN-HIM
DIN 02350297
Dosage form
- Tablet
Strength
- 10 mg
Lot or serial number
- 35329653E
- 35329655B
- 35332867A
- 35329653D
- 35329654C
- 35331730A
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
B. ratio-Atorvastatin 20 mg
DIN, NPN, DIN-HIM
DIN 02350319
Dosage form
- Tablet
Strength
- 20 mg
Lot or serial number
- 35330655C
- 35332981A
- 35206789A
- 35330656A
- 35330657A
- 35206790A
- 35206041A
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
C. ratio-Atorvastatin 40 mg
DIN, NPN, DIN-HIM
DIN 02350327
Dosage form
- Tablet
Strength
- 40 mg
Lot or serial number
- 35329657E
- 35329657D
- 35329657F
- 35329658B
- 35205661A
- 35206094A
- 35206618A
- 35329658D
- 35329659B
- 35332883A
- 35206142A
- 35206619A
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
D. ratio-Atorvastatin 80 mg
DIN, NPN, DIN-HIM
DIN 02350335
Dosage form
- Tablet
Strength
- 80 mg
Lot or serial number
- 35329660B
- 35329661B
- 35329662B
- 35332813A
- 35206368A
- 35206791A
- 35206792A
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA